Biosimilars: Evidential standards for health technology assessment.

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

StandardStandard

Biosimilars: Evidential standards for health technology assessment. / Hughes, D.; Hughes, D.A.
2009. Papur a gyflwynwyd yn Clinical Pharmacology Colloquium, Oxford, June 2009..

Allbwn ymchwil: Cyfraniad at gynhadledd › Papur

HarvardHarvard

Hughes, D & Hughes, DA 2009, 'Biosimilars: Evidential standards for health technology assessment.', Papur a gyflwynwyd yn Clinical Pharmacology Colloquium, Oxford, June 2009., 3/01/01.

APA

Hughes, D., & Hughes, D. A. (2009). Biosimilars: Evidential standards for health technology assessment.. Papur a gyflwynwyd yn Clinical Pharmacology Colloquium, Oxford, June 2009..

CBE

Hughes D, Hughes DA. 2009. Biosimilars: Evidential standards for health technology assessment. Papur a gyflwynwyd yn Clinical Pharmacology Colloquium, Oxford, June 2009..

MLA

Hughes, D. a D.A. Hughes Biosimilars: Evidential standards for health technology assessment.. Clinical Pharmacology Colloquium, Oxford, June 2009., 03 Ion 0001, Papur, 2009.

VancouverVancouver

Hughes D, Hughes DA. Biosimilars: Evidential standards for health technology assessment.. 2009. Papur a gyflwynwyd yn Clinical Pharmacology Colloquium, Oxford, June 2009..

Author

Hughes, D. ; Hughes, D.A. / Biosimilars: Evidential standards for health technology assessment. Papur a gyflwynwyd yn Clinical Pharmacology Colloquium, Oxford, June 2009..

RIS

TY - CONF

T1 - Biosimilars: Evidential standards for health technology assessment.

AU - Hughes, D.

AU - Hughes, D.A.

PY - 2009/1/1

Y1 - 2009/1/1

M3 - Paper

T2 - Clinical Pharmacology Colloquium, Oxford, June 2009.

Y2 - 3 January 0001

ER -